Furthermore, numerous studies with reliable experiments have demonstrated that the activation of the p53 signaling pathway is correlated with the development of various types of cancer, including prostate cancer (Gao et al., 2014; Gao et al., 2020; Zheng et al., 2020; Dong et al., 2021). Here, TP53 is linked to cancer.